245743-64-0 Usage
Description
Methyl 5-chloro-2-fluoro-4-hydroxybenzoate is a chemical compound with the molecular formula C8H6ClFO3. It is a derivative of benzoic acid and belongs to the class of organic compounds known as salicylic acid and derivatives. methyl 5-chloro-2-fluoro-4-hydroxybenzoate possesses antimicrobial and anti-inflammatory properties, making it a versatile ingredient in various applications.
Uses
Used in Pharmaceutical Industry:
Methyl 5-chloro-2-fluoro-4-hydroxybenzoate is used as an active pharmaceutical ingredient for its antimicrobial and anti-inflammatory properties. It aids in the development of medications targeting a range of conditions, including bacterial and inflammatory disorders.
Used in Industrial Chemical Production:
methyl 5-chloro-2-fluoro-4-hydroxybenzoate is utilized as an intermediate in the synthesis of other industrial chemicals. Its unique properties allow it to be a key component in the creation of various chemical products used across different industries.
Used as a Pesticide:
Methyl 5-chloro-2-fluoro-4-hydroxybenzoate is used as a pesticide due to its ability to inhibit the growth of microorganisms. Its application helps protect crops and enhance agricultural productivity by controlling pests and diseases.
Used as a Fungicide:
Similarly, this compound is employed as a fungicide, leveraging its antimicrobial properties to prevent the growth of fungi that can damage crops and other plants. This use contributes to the overall health and yield of agricultural products.
Check Digit Verification of cas no
The CAS Registry Mumber 245743-64-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,4,5,7,4 and 3 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 245743-64:
(8*2)+(7*4)+(6*5)+(5*7)+(4*4)+(3*3)+(2*6)+(1*4)=150
150 % 10 = 0
So 245743-64-0 is a valid CAS Registry Number.
245743-64-0Relevant articles and documents
NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS
-
Paragraph 0291, (2019/01/21)
The present invention discloses compounds according to Formula (I) Wherein R1, R2, L, A1, A2, A3, Cy and the subscript n are as defined herein. The present invention relates to antagonists compounds of sphingosine 1-phosphate (SIP) receptor, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of diseases involving fibrotic diseases, inflammatory diseases, respiratory diseases, autoimmune diseases, metabolic diseases, cardiovascular diseases, and/or proliferative diseases by administering the compound of the invention.
Design of photonic liquid crystal materials: Synthesis and evaluation of new chiral thioindigo dopants designed to photomodulate the spontaneous polarization of ferroelectric liquid crystals
Dinescu, Liviu,Maly, Kenneth E.,Lemieux, Robert P.
, p. 1679 - 1686 (2007/10/03)
Irradiation of a ferroelectric S(c)* liquid crystal phase induced by the photochromic dopants (R,R)-6,6'-bis(2-octyloxy)-5,5'-dinitrothioindigo and (R,R)-5,5'-dichloro-6,6'-bis(2-octyloxy)thioindigo at λ=514 and 532 nm, respectively, causes an increase in spontaneous polarization (P(s)) by a factor ranging from 1.4 to 4.0. This increase in P(s) is achieved without concomitant destabilization of the S(c)* phase, and is consistent with an increase in transverse dipole moment of the thioindigo core as a result of trans-cis photoisomerization. The contribution of the thioindigo core towards P(s) is achieved through stereo-polar coupling with the chiral side-chains, which is enhanced by the presence of the nitro and chloro substituents.
